Task: Answer the following question about the molecule with SMILES CCOC(=O)c1ncn2c1CN(C)C(=O)c1c(I)cccc1-2.
Request: Please describe this drug.
Completion: Iomazenil is under investigation in clinical trial NCT01590277 (Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans).
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CCOC(=O)c1ncn2c1CN(C)C(=O)c1c(I)cccc1-2
CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC=C3I)C
ethyl 7-iodo-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
Please describe this drug.
Iomazenil is under investigation in clinical trial NCT01590277 (Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans).